Zhou, X., Cai, G., Mao, S., Xu, D., Xu, X., Zhang, R., & Yao, Z. (2020). Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: Effects of clozapine combining with PQQ treatment and possible mechanisms of action. BMC.
Chicago Style (17th ed.) CitationZhou, Xingqin, Gangming Cai, Shishi Mao, Dong Xu, Xijie Xu, Rongjun Zhang, and Zhiwen Yao. Modulating NMDA Receptors to Treat MK-801-induced Schizophrenic Cognition Deficit: Effects of Clozapine Combining with PQQ Treatment and Possible Mechanisms of Action. BMC, 2020.
MLA引文Zhou, Xingqin, et al. Modulating NMDA Receptors to Treat MK-801-induced Schizophrenic Cognition Deficit: Effects of Clozapine Combining with PQQ Treatment and Possible Mechanisms of Action. BMC, 2020.
警告:這些引文格式不一定是100%准確.